David Schenkein – Biography

Last update: 3 days ago

Executive profile

David was Senior Vice President, Clinical Hematology/Oncology at Genentech, and Senior Vice President, Clinical Research and Development at Millennium Pharmaceuticals. David served as Chief Executive Officer at Denali Therapeutics.

David Schenkein is currently

Create your alert
to follow the career of David Schenkein.

Education

David Schenkein has a Bachelor of Arts in Chemistry from Wesleyan University and a Doctor of Medicine from State University of New York Medical University.

They have also studied at Wesleyan University :

Find more alumni from Wesleyan University


The colleagues of David Schenkein

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, David Schenkein has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of David Schenkein.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.